Hepatitis Research and Treatment

Clinical Study

Tumor Necrosis Factor Receptor 1 Expression Is Upregulated in Dendritic Cells in Patients with Chronic HCV Who Respond to Therapy

Table 4

(a) TNFR1 mRNA Levels in genotype 1 SVR during IFN based therapy. (b) TNFR1 levels in genotype 1 non-responders/relapsers during IFN-based therapy.
(a)
week 0week 4–1214–24 wks25–48 wks
Patient 10.967.83
Patient 21.397.131.970.71
Patient 34.237.613.86
Patient 48.4423.48
Patient 50.150.63
Patient 66.4219.7711.73
Patient 70.870.82
Patient 80.291.45
Patient 90.1511.46
Patient 101.241.52
Patient 110.4335.938.04
Patient 12 0.06 18.20
Patient 13 0.29 0.22
(b)
week 0week 4–1214–2425–48
Patient 11.534.73
Patient 20.671.14
Patient 32.730.17
Patient 42.610.98
Patient 52.976.54
Patient 60.644.070.16
Patient 71.252.71
Patient 82.831.200.34
Patient 90.260.100.11
Patient 100.730.15
Patient 110.080.05
Patient 12 0.46 0.14